Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 10 shares. Based on an average trading volume of 745 shares, the days-to-cover ratio is presently 0.0 days.
Avacta Group Stock Performance
AVCTF opened at $0.85 on Wednesday. The stock’s fifty day simple moving average is $0.94 and its 200 day simple moving average is $0.96. Avacta Group has a 1-year low of $0.74 and a 1-year high of $1.23.
Avacta Group Company Profile
Avacta Group plc is a United Kingdom-based life sciences company focused on developing targeted cancer treatments. Its principal technology platform, pre|CISION, is designed to activate medicines selectively within the tumor microenvironment, with the goal of improving treatment effectiveness while reducing exposure to healthy tissue.
The company’s lead clinical program is AVA6000, a tumor-activated form of doxorubicin being investigated for the treatment of solid tumors, including soft-tissue sarcoma.
See Also
- Five stocks we like better than Avacta Group
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
